Hereditary Angioedema
- PMID: 29489144
- Bookshelf ID: NBK482266
Hereditary Angioedema
Excerpt
Hereditary angioedema (HAE) is an autosomal dominant disease caused by the lack of or a dysfunctional C1-inhibitor protein. For this reason, the nomenclature has been developed to replace the initial use of type 1, 2, or 3 HAE. Instead, the names are HAE with deficient C1-inhibitor (type 1), HAE with dysfunctional C1-inhibitor (type 2), and HAE with normal C1-inhibitor. Though unique in the testing that leads to the diagnosis, they all behave similarly with angioedema. The following discussion focuses on type 1 and 2 HAE. Secondary to a lack of diagnostic tests for most case of HAE with normal C1-inhibitor, multiple different variants, and lack of FDA approved therapy, HAE with normal C1-inhibitor is not included below.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Zhang Y, Tortorici MA, Pawaskar D, Pragst I, Machnig T, Hutmacher M, Zuraw B, Cicardi M, Craig T, Longhurst H, Sidhu J. Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema. CPT Pharmacometrics Syst Pharmacol. 2018 Mar;7(3):158-165. - PMC - PubMed
-
- Lumry WR. Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema. Am J Manag Care. 2013 Jun;19(7 Suppl):s103-10. - PubMed
-
- Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008 Sep 04;359(10):1027-36. - PubMed
-
- Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976 May;84(5):580-93. - PubMed
-
- Cicardi M, Zuraw BL. Angioedema Due to Bradykinin Dysregulation. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1132-1141. - PubMed
Publication types
LinkOut - more resources
Full Text Sources